Bionano to Participate in the H.C. Wainwright @ Home Event
Bionano Genomics (Nasdaq: BNGO) said CEO Erik Holmlin, PhD will participate in the H.C. Wainwright @ Home Event on October 15, 2025. The session runs 10:00 a.m. to 11:00 a.m. ET and will be available via webcast with a registration link.
A replay/recording will be posted on the company investor website at ir.bionano.com and remain available for at least 90 days after the event.
Bionano Genomics (Nasdaq: BNGO) ha detto che il CEO Erik Holmlin, PhD parteciperà all'evento H.C. Wainwright @ Home il 15 ottobre 2025. La sessione si svolgerà dalle 10:00 alle 11:00 ET e sarà disponibile tramite webcast con un link di registrazione.
Una replica/registrazione verrà pubblicata sul sito degli investitori dell'azienda all'indirizzo ir.bionano.com e rimarrà disponibile per almeno 90 giorni dopo l'evento.
Bionano Genomics (Nasdaq: BNGO) dijo que el CEO Erik Holmlin, PhD participará en el H.C. Wainwright @ Home Event el 15 de octubre de 2025. La sesión se llevará a cabo de 10:00 a.m. a 11:00 a.m. ET y estará disponible vía webcast con un enlace de registro.
Una reproducción/grabación será publicada en el sitio de inversores de la empresa en ir.bionano.com y estará disponible por al menos 90 días después del evento.
Bionano Genomics (나스닥: BNGO)의 CEO Erik Holmlin, PhD가 2025년 10월 15일에 열리는 H.C. Wainwright @ Home Event에 참여한다고 발표했습니다. 세션은 동부 표준시 10:00~11:00에 진행되며 등록 링크가 있는 웹캐스트로 제공됩니다.
회의의 재생/녹음본은 회사의 투자자 웹사이트 ir.bionano.com에 게시되며 행사 종료 후 최소 90일간 이용 가능합니다.
Bionano Genomics (Nasdaq : BNGO) a annoncé que le PDG Erik Holmlin, PhD participera à l'événement H.C. Wainwright @ Home le 15 octobre 2025. La session se déroulera de 10h00 à 11h00, heure de l'Est et sera disponible en webcast avec un lien d'inscription.
Une rediffusion/enregistrment sera publiée sur le site des investisseurs de l'entreprise à l'adresse ir.bionano.com et restera disponibles pendant au moins 90 jours après l'événement.
Bionano Genomics (Nasdaq: BNGO) sagte, dass CEO Erik Holmlin, PhD am H.C. Wainwright @ Home Event am 15. Oktober 2025 teilnehmen wird. Die Sitzung läuft von 10:00 bis 11:00 Uhr ET und wird über Webcast mit einem Registrierungslink verfügbar sein.
Eine Wiedergabe/Aufzeichnung wird auf der Investoren-Website des Unternehmens unter ir.bionano.com veröffentlicht und bleibt mindestens 90 Tage nach der Veranstaltung zugänglich.
Bionano Genomics (ناسداك: BNGO) قالت أن الرئيس التنفيذي Erik Holmlin، دكتوراه سيشارك في فعالية H.C. Wainwright @ Home في 15 أكتوبر 2025. ستعقد الجلسة من 10:00 صباحًا حتى 11:00 صباحًا بتوقيت الساحل الشرقي وستكون متاحة عبر بث مباشر مع رابط تسجيل.
سيتم نشر إعادة التشغيل/التسجيل على موقع المستثمرين للشركة عند ir.bionano.com وستظل متاحة لمدة لا تقل عن 90 يومًا بعد الحدث.
Bionano Genomics (纳斯达克：BNGO) 表示 CEO Erik Holmlin，博士 将在 2025年10月15日 参加 H.C. Wainwright @ Home 活动。该会议将于 美国东部时间 10:00-11:00 举行，并将提供带注册链接的网络直播。
公司投资者网站 ir.bionano.com 将发布回放/记录，并在活动结束后至少保持可用 90 天。
- None.
- None.
SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the H.C. Wainwright @ Home Event on Wednesday, October 15th, 2025.
Conference & Webcast Details
| Date: | October 15, 2025 |
| Time: | 10:00 a.m. to 11:00 a.m. ET |
| Presenter: | Erik Holmlin, PhD, CEO of Bionano |
| Webcast: | Link to Register |
A replay / recording of the session will be available following the conference through the Bionano website at ir.bionano.com for at least 90 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.
For more information, visit www.bionano.com or www.bionanolaboratories.com.
Bionano’s products are for research use only and not for use in diagnostic procedures.
Contacts
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
When will BNGO present at the H.C. Wainwright @ Home Event?
Who from Bionano will speak at the October 15, 2025 BNGO presentation?
How can investors watch BNGO's H.C. Wainwright @ Home webcast on October 15, 2025?
Will there be a replay of the BNGO H.C. Wainwright presentation after October 15, 2025?
What topics will BNGO cover during the October 15, 2025 presentation?
Where can I find registration and replay information for BNGO (Nasdaq: BNGO)?
